KALOBIOS PHARMACEUTICALS INC (KBIO) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 97 transactions totaling $18.3M, demonstrating a bullish sentiment with $4.5M in net insider flow. The most recent transaction on Aug 26, 2016 involved a sale of 309,723 shares valued at $960.1K.
No significant insider buying has been recorded for KBIO in the recent period.
No significant insider selling has been recorded for KBIO in the recent period.
Based on recent SEC filings, insider sentiment for KBIO is bullish with an Insider Alignment Score of 62/100 and a net flow of $4.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at KALOBIOS PHARMACEUTICALS INC (KBIO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading KBIO stock, having executed 97 transactions in the past 90 days. The most active insider is Martin Shkreli (Executive), who has made 9 transactions totaling $9.7M.
Get notified when executives and directors at KBIO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 26, 2016 | Shkreli Martin | Executive | Sale | 309,723 | $3.10 | $960.1K | Large |
| Aug 25, 2016 | Shkreli Martin | Executive | Sale | 1,913,206 | $3.10 | $5.9M | Large |
| Dec 16, 2015 | Moradi David | Executive | Purchase | 3,410 | $29.32 | $100.0K | |
| Dec 16, 2015 | Moradi David | Executive | Purchase | 3,410 | $29.32 | $100.0K | |
| Dec 16, 2015 | Wayne Harrison Michael | Executive | Purchase | 1,705 | $29.32 | $50.0K | |
| Dec 16, 2015 | Biestek Marek | Executive | Purchase | 10,000 | $29.32 | $293.2K | |
| Dec 16, 2015 | Edward Fernandez Thomas | Executive | Purchase | 6,821 | $29.32 | $200.0K | |
| Dec 16, 2015 | Moradi David | Executive | Purchase | 3,410 | $29.32 | $100.0K | |
| Dec 16, 2015 | Moradi David | Executive | Purchase | 3,410 | $29.32 | $100.0K | |
| Nov 24, 2015 | Shkreli Martin | Executive | Purchase | 5,000 | $38.15 | $190.8K | |
| Nov 20, 2015 | Shkreli Martin | Executive | Purchase | 5,000 | $18.88 | $94.4K | |
| Nov 18, 2015 | Shkreli Martin | Executive | Purchase | 440,000 | $2.02 | $888.8K | Large |
| Nov 18, 2015 | Biestek Marek | Executive | Purchase | 40,000 | $2.04 | $81.6K | |
| Nov 18, 2015 | Moradi David | Executive | Purchase | 150,000 | $2.13 | $319.5K | |
| Nov 18, 2015 | Moradi David | Executive | Purchase | 150,000 | $2.13 | $319.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 38 | $11.4M | 62.4% |
Sale(S) | 2 | $6.9M | 37.6% |
Conversion(C) | 57 | $0 | 0.0% |
Insiders at KALOBIOS PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 25 insiders making 97 transactions totaling $11.4M in purchases versus $6.9M in sales, the net buying activity of $4.5M signals strong executive confidence. Martin Shkreli (Executive) leads the buying activity with $9.7M in transactions across all time.